Mitf-Signal Responsive Transcription in Osteoclasts

描述（由申请人提供）：Mitf是一种螺旋-环-螺旋转录因子，其突变在多个物种中产生重度骨硬化症。来自Mitf突变小鼠的破骨细胞谱系细胞发育，但似乎在大约融合阶段停止，并表现出严重的骨吸收缺陷。这种晚期发育缺陷表明，Mitf转录因子调节晚期破骨细胞分化基因，而不是谱系决定的全球调节因子。这些基因的鉴定和转录控制，调节其表达的立场提供了重要的新的目标，为治疗骨疾病的man. We观察到，显性负等位基因的Mitf产生严重的骨硬化症，而无效等位基因不。在此基础上，我们确定了TFE 3，一个相关的HLH因子，作为一个二聚伙伴，在破骨细胞谱系中与Mitf共享转录活性。Mitf和TFE 3的这种重叠作用已在双无效小鼠模型中得到验证。我们还证明，M-CSF，一种对早期和晚期破骨细胞发育至关重要的细胞因子，触发保守丝氨酸上的Mitf和TFE 3的MAPK磷酸化，刺激其共激活因子p300的募集。这种磷酸受体丝氨酸的突变破坏了晚期骨细胞分化。除了这种翻译后调节，我们已经确定了几个Mitf/TFE 3转录靶基因，包括分泌的蛋白酶组织蛋白酶K，和生存基因Bcl 2。这些基因的体内破坏导致骨硬化症。Mitf/TFE 3对晚期破骨细胞成熟的重要作用为通过分析其生化调控和靶基因鉴定发现骨吸收过程的关键途径和介质提供了独特的机会。我们建议在两个具体目标中进行这种分析。第一个重点是阐明调节Mitf和TFE 3表达和活性的转录和翻译后机制，这反过来又调节晚期破骨细胞发育和骨吸收。第二个代表了一个系统的方法来识别Mitf/TFE 3的转录靶点，使用屏幕将它们的生化活性与它们所处的信号通路相结合。

DESCRIPTION (provided by applicant): Mitf is a helix-loop-helix transcription factor whose mutation produces severe osteopetrosis in multiple species. Osteoclast lineage cells from Mitf-mutant mice develop, but appear to arrest at approximately the fusion stage and exhibit profoundly defective bone resorption. This late developmental defect suggests that the Mitf transcription factor regulates late osteoclast differentiation genes, rather than global regulators of lineage determination. The identification of those genes and the transcriptional controls which modulate their expression stand to provide important new targets for the treatment of bone disorders in man. We observed that dominant negative alleles of Mitf produce severe osteopetrosis whereas null alleles do not. On this basis we identified TFE3, a related HLH factor, as a dimerization partner which shares transcriptional activities with Mitf in the osteoclast lineage. This overlapping role for Mitf and TFE3 has been verified in a double-null mouse model. We have also demonstrated that M-CSF, a vital cytokine for both early and late osteoclast development, triggers MAPK phosphorylation of both Mitf and TFE3 on a conserved serine, stimulating their recruitment of the coactivator p300. Mutation of this phosphoacceptor serine disrupts late osteoclastic differentiation. In addition to this post-translational regulation, we have identified several Mitf/TFE3 transcriptional target genes including the secreted protease cathepsin K, and the survival gene Bcl2. In vivo disruption of these genes results in osteopetrosis. The essential roles for Mitf/TFE3 specifically for late osteoclast maturation affords a unique opportunity to discover key pathways and mediators of the bone resorption process through the analysis of their biochemical regulation and target gene identification. We propose to carry out this analysis in two Specific Aims. The first focuses on elucidating transcriptional and post-translational mechanisms which regulate expression and activity of Mitf and TFE3, which in turn modulate late osteoclast development & bone resorption. The second represents a systematic approach to the identification of transcriptional targets of Mitf/TFE3 using screens which couple their biochemical activities to the signaling pathways in which they reside.